DNAM-1 is an activating receptor expressed on NK cells and T cells and plays an 3 important role in cytotoxicity of these cells against target cells. Although the role of DNAM-1 4 in the function of T cells and NK cells has been well studied, the expression and function of 5 DNAM-1 on myeloid cells have been incompletely understood. In this study, we investigated 6 expression of DNAM-1 on monocyte subsets in mouse peripheral blood and found that only 7 inflammatory monocytes (iMos), but not patrolling monocytes (pMos), expressed high levels 8
and NK cells are well known (Bottino et al., 2003; Iguchi-Manaka et al., 2008; Martinet and 7 Smyth, 2015; Nabekura et al., 2010; Tahara-Hanaoka, 2004; Verhoeven et al., 2008) , the 8 functional role of DNAM-1 in myeloid cells is incompletely understood. Therefore we aimed 9 to investigate expression profile of DNAM-1 on mouse peripheral blood cells, especially on 10 circulating myeloid cell populations. Peripheral bloods and splenocytes from wild type (WT) 11 and DNAM-1-deficient (Cd226 -/-) mice were collected and DNAM-1 expression on myeloid 12 cell subsets and lymphocytes subsets were analyzed by flowcytometry. After CD11c + DCs 13 and Ly6G + neutrophils in the peripheral blood were gated out, CD11b + monocytes were 14 divided into two populations on the basis of Ly6C expression ( Fig. 1A, B ). Eosinophils were 15 gated by Siglec-F (Fig. 1C ). Among myeloid cell subsets, we found that Ly6C hi iMos obtained 16 from WT mice strongly expressed DNAM-1. In contrast, Ly6C lo pMos did not express 17 DNAM-1, showing a striking difference of DNAM-1 expression on these distinct monocyte 18 subsets ( Fig. 1A, B ). 1 Surprisingly, DNAM-1 was expressed on most circulating neutrophils at an 2 intermediate level (Fig. 1A) . This result was contrary to splenic neutrophils of which only a 3 small subset expressed low levels of DNAM-1 (Supplementary figure) , indicating that 4 expression of DNAM-1 on neutrophils is different between the peripheral blood and the 5 spleen. DNAM-1 was also expressed on most eosinophils and on a small population of 6 dendritic cells ( Fig. 1A, C) . DNAM-1 expression on CD4 + and CD8 + T cells and NK cells in 7 peripheral blood of mice ( Fig. 1D ) were similar to that in spleen cells (Supplementary figure) . 8 9
DNAM-1 expression on human monocytes. 10
We next investigated DNAM-1 expression on human counterparts of monocyte 11 subsets. PBMCs were isolated from healthy donors and analyzed by flowcytometry. After 12 excluding CD14 -CD16cells (T cells, B cells, and DCs) and HLA-DR -CD16 + cells 13 (contaminated neutrophils and NK cells) (Abeles et al., 2012), CD14 + CD16 -iMos and 14 CD14 lo CD16 + pMos were analyzed. Similar to mouse iMos, CD14 + CD16human iMos 15 strongly expressed DNAM-1 ( Fig. 2A) . In contrast, pMos, defined as CD14 lo CD16 + cells, 16 scarcely expressed DNAM-1 ( Fig. 2A ). Five independent donors were studied and the mean 12 fluorescent intensity of DNAM-1 on iMos was significantly higher than that of pMos ( Fig.  1   2B) . Thus, selective expression of DNAM-1 on iMos is conserved between mice and humans, 2 suggesting that DNAM-1 is evolutionally conserved and plays an important role in the 3 function of iMos. It is known that heterogeneity of monocytes is conserved among 4 mammalian species including human, mouse, rat, and pig (Ancuta et al., 2009; Gordon and 5 Taylor, 2005) . Expression of some chemokine receptors and adhesion molecules is conserved 6 between species. Among these, stronger expression of surface molecules that contribute to the 7 major function of each subsets, such as CCR2 and CD62L on iMos and CX 3 CR1 on pMos, 8 appears to be well conserved (Gordon and Taylor, 2005) . In this context, DNAM-1 can be 9 newly recognized as surface molecule that defines two subsets of monocytes. DNAM-1 10 expression on other mammalian species is of interest. 11 12
DNAM-1 is involved in cell adhesion of mouse iMos. 13
Because DNAM-1 is an adhesion molecule (Shibuya et al., 1996) , we next 14 addressed the involvement of DNAM-1 in adhesion ability of iMos. Although CD155 and 15 CD112 are ligands for DNAM-1 and both ligands are expressed on human endotherial cells 16 (Lopez et al., 1998; Reymond et al., 2004) , a previous report suggested that CD155 is solely 13 an important ligand on human endothelial cells for DNAM-1 (Reymond et al., 2004) . 1 Therefore we examined the role of DNAM-1 on iMos in adhesion to CD155. Ba/F3 or Ba/F3 2 transfectant expressing CD155 (Fig.3A) were seeded on a 96 well cell culture plate, and then 3 CFSE-labeled iMos from peripheral blood of WT or Cd226 -/mice were added over the plate. 4
After washing, remaining of iMos was counted under fluolescent microscope. iMos from 5
Cd226 -/mice showed lower ability of adhesion to CD155-expressing Ba/F3 transfectants 6 compared with those from WT mice; in contrast, this difference in adhesion ability was not 7 observed in Ba/F3 parental cells ( Fig. 3B, C) . Furthermore, adhesion of iMos was 8 downregulated when iMos were pre-incubated with anti-DNAM-1 neutralizing antibody ( Fig.  9 3D). Taken together, these results indicate that DNAM-1 is involved in iMos adhesion to 10 CD155-expressing cells. Given that CD155 is expressed on mouse endothelial cells (Maier et 11 al., 2007) , our results suggest that DNAM-1 may be involved in transendotherial migration of 12 mouse iMos. Although previous reports showed that interaction of DNAM-1 on human 13 monocytes with CD155 on endothelial cells was involved in transmigration in vitro (Manes 14 and Pober, 2011; Reymond et al., 2004; Sullivan et al., 2013) , physiological role of DNAM-1 15 −CD155 interaction in monocyte transmigration has not been addressed in vivo. Since iMos 16
highly expressed DNAM-1 in mice as well, contribution of DNAM-1−CD155 interaction 14 could be observed in vivo model in mice. 1 pMos crawl along the endothelial cells of blood vessel in steady state and rapidly 2 migrate out of the circulation into inflamed tissue within 1 hour after inflammation occurs 3 (Auffray et al., 2009 (Auffray et al., , 2007 Geissmann et al., 2003; Soehnlein and Lindbom, 2010) . In 4 contrast, iMos are selectively recruited into inflamed tissues and lymph nodes after several 5 hours from the initiation of infection (Auffray et al., 2009 (Auffray et al., , 2007 Shi and Pamer, 2011) . The 6 difference of the migratory characteristics of these monocyte subsets has been explained by 7 expression profile of chemokine receptors such as CCR2 and CX 3 CR1 (Ancuta et al., 2009; 8 Gordon and Taylor, 2005) . Here we revealed that DNAM-1 is expressed on iMos, but not on 9 pMos, in humans and mice and that DNAM-1 on mouse iMos is involved in iMos adhesion to 10 CD155-expressing cells, suggesting that DNAM-1 is involved in transmigration of iMos 11 through endothelial cells, which express CD155, into inflamed tissues. Although iMos in the 12 bloodstream are derived from the bone marrow following bacterial infection (Ginhoux and 13 Jung, 2014; Serbina and Pamer, 2006; Shi and Pamer, 2011) , the dynamics of DNAM-1 14 expression on iMos in the bone marrow, blood and inflamed tissue remain unclear. However, 15 since DNAM-1 expression is upregulated on T cells, NK cells, and platelets during their Ancuta, P., Liu, K., Misra, V., Wacleche, V.S., Gosselin, A., Zhou, X., Gabuzda, D., 2009. 13 Transcriptional profiling reveals developmental relationship and distinct biological 14 functions of CD16+ and CD16-monocyte subsets. BMC Genomics 10, 403. 15 doi:10.1186/1471-2164-10-403 16
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